Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session

150P - The Prognostic Nutritional Index is linked to textbook outcomes and the status of lymphocyte infiltration in patients with perihilar cholangiocarcinoma

Date

07 Dec 2024

Session

Poster Display session

Presenters

Qin-qin Liu

Citation

Annals of Oncology (2024) 35 (suppl_4): S1450-S1504. 10.1016/annonc/annonc1688

Authors

Z. Chen1, H. Lin1, R. Zhang1, Q. Liu2

Author affiliations

  • 1 Biliary-pancreatic Surgery, Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, 510120 - Guangzhou/CN
  • 2 Biliary-pancreatic Surgery, Sun Yat-Sen University, 510275 - Guangzhou/CN

Resources

This content is available to ESMO members and event participants.

Abstract 150P

Background

The status of PNI, a recognized immunonutritional marker, shows significant potential for forecasting oncological results. Textbook Outcomes (TOs) serve as thorough assessment tools for evaluating surgical outcomes. The connection between PNI, patient prognosis, and TOs in perihilar cholangiocarcinoma (pCCA) is still uncertain. This study seeks to assess the associations between PNI and TOs, as well as elucidate the status of lymphocyte infiltration at varying PNI levels in pCCA patients.

Methods

In this study, a retrospective study was conducted on 105 pCCA patients who underwent surgery with curative intent. Our examination focused on assessing the potential effects of PNI levels on patient oncological outcomes and Textbook Outcomes (TOs). Additionally, we aimed to analyze the relationship between PNI levels and the immune microenvironment.

Results

Patients with a high PNI showed a significantly extended overall survival (OS) compared to those with a lower PNI (24.7 months vs. 9.5 months, P=0.001). Multivariate analysis confirmed PNI (P=0.001) and TOs (P=0.044) as independent risk factors associated with OS. Further investigations revealed that patients with different PNI levels in pCCA displayed distinct immune microenvironments, with high PNI levels correlated with increased peritumoral CD3+ T cell and CD8+ T cell infiltration.

Conclusions

Patients with pCCA who have a high PNI demonstrate favorable oncological outcomes and a higher incidence of achieving TOs. Therefore, PNI could potentially be utilized as a valuable tool to help physicians predict patient prognosis and the likelihood of achieving TOs.

Clinical trial identification

SYSKY-2024-468-01.

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.